David Abrams started to build up the position in Akebia Therapeutics in Q3 2018 and continued to invest until Q4 2018. Since then they sold 5.66 Million shares. The investor sold all their shares in Q4 2020 and doesn't own any shares in Akebia Therapeutics anymore.